NCT01883817View on ClinicalTrials.gov

Effect of Omega-3 Fatty Acid on Cortical Function in ADHD

PHASE3CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

March 3, 2017

Study Completion Date

March 3, 2017

Conditions
Attention Deficit Disorder
Interventions
DRUG

DHA Omega-3

Patients will receive a fixed dose of DHA (1,200 mg/day, 600 mg twice daily) or placebo (corn/soy oil) over 10 weeks

DRUG

Placebo

corn/soy oil capsule with similar color, taste, and shape as experimental drug (DHA)

Trial Locations (1)

45219

University of Cincinnati, Department of Psychiatry and Behavioral Neuroscience, Cincinnati

All Listed Sponsors
collaborator

DSM Nutritional Products, Inc.

INDUSTRY

lead

University of Cincinnati

OTHER

NCT01883817 - Effect of Omega-3 Fatty Acid on Cortical Function in ADHD | Biotech Hunter | Biotech Hunter